Acute Renal Insufficiency (ARI) Rate and Predictive Score of ARI in Hospitalized Patients for Acute Coronary Syndrome With ST-segment Elevation Needing Urgent Coronarography
NCT ID: NCT04481126
Last Updated: 2021-09-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
168 participants
OBSERVATIONAL
2020-07-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The secondary objectives are:
* identify factors of risks associated with the occurrence of acute renal insufficiency after coronarography.
* establish a preprocedure score, predicting of acute renal insufficiency after urgent coronary angiography in patients with ST+ acute coronary syndrome.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Frequency and Risk Factors of Congestive Heart Failure in Dialysis Patients
NCT04441346
Development of an Innovative Clinico-biological Score for the Early Detection of Acute Renal Failure Associated With Cardiac Surgery.
NCT05283213
Predicting Acute Kidney Injury After Coronary Artery Bypass Graft
NCT02081261
Identification of Cardiovascular Risk Factors Linked to Renal Failure Progression
NCT00608998
An Early Real-Time Electronic Health Record Risk Algorithm for the Prevention and Treatment of Acute Kidney Injury
NCT03590028
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* evocative symptoms of myocardiac ischemia: typical chest pain; ST-segment elevation and 1 mm in two consecutive peripheral leads and 2 mm in two consecutive precordial derivations, or appearance of a bloc of left branch of novo;
* need urgent coronarography;
* Covered by french social security scheme included CMU.
Exclusion Criteria
* cardio-resporatory arrest;
* cardiogenic choc state;
* prior emergency passage to hospital;
* patient under tutor, gardianship;
* patient covered by french AME scheme;
* pregnant women or breastfeeding;
* all medical, psychological or social situation which should influents the compliance to protocol according to investigator;
* patient refusal.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paul GABARRE, MD
Role: PRINCIPAL_INVESTIGATOR
Nephrology department, Ambroise Paré hospital, APHP
Eve Vilaine, MD
Role: STUDY_DIRECTOR
Nephrology department, Ambroise Paré hospital, APHP
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nephrology department, Ambroise Paré hospital, APHP
Boulogne-Billancourt, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APHP201021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.